KYORIN Pharmaceutical Co., Ltd. (TYO:4569)

Revenue by Segment

Financials in millions JPY. Fiscal year is April - March.

Fiscal Year	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017
Period Ending	Mar 31, 2026	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022	Mar 31, 2021	Mar 31, 2020	Mar 31, 2019	Mar 31, 2018	Mar 31, 2017
Pharmaceuticals	126.26B	130.09B	119.53B	113.27B	105.53B
Pharmaceuticals Growth	-2.94%	8.83%	5.53%	7.33%	2.56%
Total	126.26B	130.09B	119.53B	113.27B	105.53B
Total Growth	-2.94%	8.83%	5.53%	7.33%	2.56%

Revenue by Geography

Financials in millions JPY. Fiscal year is April - March.

Fiscal Year	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017
Period Ending	Mar 31, 2026	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022	Mar 31, 2021	Mar 31, 2020	Mar 31, 2019	Mar 31, 2018	Mar 31, 2017
Japan	87.11B	84.16B	82.58B	74.77B	69.73B
Japan Growth	3.51%	1.91%	10.45%	7.24%	-0.01%
Overseas	693.00M	8.86B	386.00M	308.00M	1.03B
Overseas Growth	-92.18%	2195.34%	25.32%	-70.18%	3.71%
Unallocated	38.45B	37.07B	36.56B	38.19B	34.78B
Unallocated Growth	3.73%	1.38%	-4.26%	9.82%	8.09%
Total	126.26B	130.09B	119.53B	113.27B	105.53B
Total Growth	-2.94%	8.83%	5.53%	7.33%	2.56%

Data Source: S&P Global Market Intelligence Last updated: Mar 31, 2026

Financial data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Jul 14, 2026

Data Sources Report a data error